Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Oo

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|May 23, 2002
Lack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirinCharles Oo, Joanne Barrett, Albert Dorr, et al.
Drug Safety|August 12, 2003
Safety and pharmacology of oseltamivir in clinical useRegina Dutkowski, Bharat Thakrar, Enrico Froehlich, et al.
European Journal of Clinical Pharmacology|August 12, 2003
Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 yearsCharles Oo, George Hill, Albert Dorr, et al.
International Journal of Pharmaceutics|April 25, 2003
Pharmacokinetics and delivery of the anti-influenza prodrug oseltamivir to the small intestine and colon using site-specific delivery capsulesCharles Oo, Paul Snell, Joanne Barrett, et al.
American Journal of Therapeutics|March 21, 2009
Population pharmacokinetics of the selective serotonin 5-HT1A receptor partial agonist piclozotanJohn T Mondick, Charles Oo, Dimple Patel, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 8, 2006
Reciprocating dialysis tube method: periodic tapping improved in vitro release/dissolution testing of suppositoriesSoichi Itoh, Naomi Teraoka, Toshio Matsuda, et al.
Clinical Pharmacokinetics|August 10, 2022
Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic ModelingShixing Zhu, Jiayuan Zhang, Zhihua Lv, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2001
The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studiesGeorge Hill, Tomas Cihlar, Charles Oo, et al.
Frontiers in Microbiology|October 10, 2022
Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant <i>Acinetobacter baumannii</i>Shixing Zhu, Jiayuan Zhang, Chu Song, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 12, 2023
Physiologically-based pharmacokinetic modeling to inform dosing regimens and routes of administration of rifampicin and colistin combination against Acinetobacter baumanniiJiayuan Zhang, Chu Song, Mengyuan Wu, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|May 23, 2002
Lack of pharmacokinetic interaction between the oral anti-influenza prodrug oseltamivir and aspirinCharles Oo, Joanne Barrett, Albert Dorr, et al.
Drug Safety|August 12, 2003
Safety and pharmacology of oseltamivir in clinical useRegina Dutkowski, Bharat Thakrar, Enrico Froehlich, et al.
European Journal of Clinical Pharmacology|August 12, 2003
Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 yearsCharles Oo, George Hill, Albert Dorr, et al.
International Journal of Pharmaceutics|April 25, 2003
Pharmacokinetics and delivery of the anti-influenza prodrug oseltamivir to the small intestine and colon using site-specific delivery capsulesCharles Oo, Paul Snell, Joanne Barrett, et al.
American Journal of Therapeutics|March 21, 2009
Population pharmacokinetics of the selective serotonin 5-HT1A receptor partial agonist piclozotanJohn T Mondick, Charles Oo, Dimple Patel, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 8, 2006
Reciprocating dialysis tube method: periodic tapping improved in vitro release/dissolution testing of suppositoriesSoichi Itoh, Naomi Teraoka, Toshio Matsuda, et al.
Clinical Pharmacokinetics|August 10, 2022
Prediction of Tissue Exposures of Meropenem, Colistin, and Sulbactam in Pediatrics Using Physiologically Based Pharmacokinetic ModelingShixing Zhu, Jiayuan Zhang, Zhihua Lv, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2001
The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studiesGeorge Hill, Tomas Cihlar, Charles Oo, et al.
Frontiers in Microbiology|October 10, 2022
Metabolomic profiling of polymyxin-B in combination with meropenem and sulbactam against multi-drug resistant <i>Acinetobacter baumannii</i>Shixing Zhu, Jiayuan Zhang, Chu Song, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 12, 2023
Physiologically-based pharmacokinetic modeling to inform dosing regimens and routes of administration of rifampicin and colistin combination against Acinetobacter baumanniiJiayuan Zhang, Chu Song, Mengyuan Wu, et al.
Pageof 4